RNA-targeting small molecule company Arrakis raises $75M series B

Arrakis raised $75 million in a series B round led by venBio and Nextech Invest.

Also participating were new investors Omega Funds, HBM Healthcare Investments, GV, WuXi AppTec Co. Ltd. (Shanghai:603259; HKSE:2359) and Alexandria Venture Investments, as well as returning investors Canaan Partners, Advent Life Sciences, Pfizer Ventures, Celgene Corp. (NASDAQ:CELG), Osage University Partners and the estate of Henri Termeer...